Literature DB >> 3331679

Absence of genotoxic effects in cells exposed to four ketonucleoside derivatives.

M A Alaoui-Jamali1, C Lasne, K Antonakis, I Chouroulinkov.   

Abstract

The relationship between the structure and genotoxic potential of four new cytostatic compounds--the ketonucleosides KN-35, KN-43, KN-44 and KN-3--was investigated in short-term in vitro assays of hypoxanthine-guanine phosphoribosyl transferase locus mutation in V79 cells, induction of chromosomal aberrations and sister chromatid exchanges on human lymphocytes, induction of chromosomal aberrations and micronuclei in V79 cells, and transformation of Syrian hamster embryo cells. None of the ketonucleosides induced mutagenic effects in any of the assays. Their failure to exhibit significantly genotoxic activity may be ascribed to the probable absence of any reaction between these drugs and the cellular DNA, and indicates that they act by some other mechanism which probably differs from the one observed with alkylating or intercalating antitumoural agents. This suggests that the cytotoxic activity of ketonucleosides cannot be related to genotoxicity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3331679     DOI: 10.1093/mutage/1.6.411

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  17 in total

1.  Antiproliferative and apoptotic activities of ketonucleosides and keto-C-glycosides against non-small-cell lung cancer cells with intrinsic drug resistance.

Authors:  J Paterson; C Uriel; M J Egron; J Herscovici; K Antonakis; M A Alaoui-Jamali
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Plant miR171 modulates mTOR pathway in HEK293 cells by targeting GNA12.

Authors:  Angelo Gismondi; Valentina Nanni; Valentina Monteleone; Claudia Colao; Gabriele Di Marco; Antonella Canini
Journal:  Mol Biol Rep       Date:  2021-01-01       Impact factor: 2.316

Review 3.  Tumour metabolism and its unique properties in prostate adenocarcinoma.

Authors:  David A Bader; Sean E McGuire
Journal:  Nat Rev Urol       Date:  2020-02-28       Impact factor: 14.432

Review 4.  Amino acids and amino acid sensing: implication for aging and diseases.

Authors:  Serena Dato; Eneida Hoxha; Paolina Crocco; Francesca Iannone; Giuseppe Passarino; Giuseppina Rose
Journal:  Biogerontology       Date:  2018-09-25       Impact factor: 4.277

Review 5.  Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunction.

Authors:  Yukun Zhu; Xuewen Liu; Xuelu Ding; Fei Wang; Xin Geng
Journal:  Biogerontology       Date:  2018-09-18       Impact factor: 4.277

6.  Leucine regulates autophagy via acetylation of the mTORC1 component raptor.

Authors:  Sung Min Son; So Jung Park; Eleanna Stamatakou; Mariella Vicinanza; Fiona M Menzies; David C Rubinsztein
Journal:  Nat Commun       Date:  2020-06-19       Impact factor: 14.919

Review 7.  The Ubiquitin System: a Regulatory Hub for Intellectual Disability and Autism Spectrum Disorder.

Authors:  Stephen A Wood; Michael Piper; Maria A Kasherman; Susitha Premarathne; Thomas H J Burne
Journal:  Mol Neurobiol       Date:  2020-01-23       Impact factor: 5.590

Review 8.  mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme.

Authors:  M Janaki Ramaiah; K Rohil Kumar
Journal:  Mol Biol Rep       Date:  2021-06-16       Impact factor: 2.316

9.  Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin.

Authors:  Se-Kyeong Jang; Sung-Eun Hong; Da-Hee Lee; Ji-Young Kim; Ji Yea Kim; Sang-Kyu Ye; Jungil Hong; In-Chul Park; Hyeon-Ok Jin
Journal:  BMC Cancer       Date:  2021-07-12       Impact factor: 4.430

10.  mTOR-Myc axis drives acinar-to-dendritic cell transition and the CD4+ T cell immune response in acute pancreatitis.

Authors:  Dan Xu; Rongli Xie; Zhiwei Xu; Zhifeng Zhao; Min Ding; Wei Chen; Jun Zhang; Enqiang Mao; Erzhen Chen; Ying Chen; Kaige Yang; Tong Zhou; Jian Fei
Journal:  Cell Death Dis       Date:  2020-06-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.